Using AI and optoacoustic imaging, researchers have developed a new method to assess microvascular changes in the skin – and thus the severity of diabetes in the patient.
It's an important milestone for gene editing technology: a novel treatment for sickle cell disease utilizing CRISPR-Cas9, has now received FDA approval – a first for this type of therapy.
Researchers and clinicians at Washington University in St. Louis found a way to improve diagnostic accuracy of potentially cancerous lesions in the ovaries and adnexal regions, or the fallopian tubes.
Highlights:The fully automated HbA1c Advanced assay enables mid- to high-volume laboratories to provide physicians with state-of-the-art precision and accuracy for diagnosing diabetes mellitus, monitoring long-term glucose control in individuals with diabetes mellitus and identifying patients who may be at risk of developing diabetes mellitus.National Glycohemoglobin Standardization Program…
Ten times more detail than current 7T scanners, over 50 times more than 3T: A new type of functional MRI will allow neuroscientists to more precisely localize and trace brain networks.
ETH Zurich molecular biologist Mandy Boontanrart is researching gene therapies that could be used to cure two of the most common types of inherited anaemia: beta thalassaemia and sickle cell anaemia.
Engineers have developed an electronic patch that can give medical professionals unprecedented access to crucial information that could help spot life-threatening conditions.
A device using next-gen technology to automatically deliver insulin was found to be more effective at maintaining blood glucose levels than standard-of-care management for type 1 diabetes.
In a new study, scientists from the Hematology Department, University Hospital of Clermont-Ferrand, have successfully evaluated the analytical performance of the Yumizen G DDi 2 hemostatic immunoassay.
Recently, a Korean research team has developed a 3D foot imaging technique that vividly captures peripheral blood vessels, even thinner than 1 mm. It combines photoacoustic and ultrasound images.
Researchers at the McKelvey School of Engineering at Washington University in St. Louis found a way to significantly reduce the noise and maintain image quality while reducing the laser energy needed to generate images by 80%.
The EU-funded consortium Laser and Ultrasound Co-analyzer for Thyroid Nodules (LUCA) has developed a non-invasive, low-cost device that brings a new solution for thyroid cancer screening.
Specialists from the Department of Fundamental Medicine of Far Eastern Federal University (FEFU) with Russian and Japanese colleagues have probed into mechanisms of COVID-19 inside-the-body distribution linked to erythrocytes damaging.
In 2019, the Central Laboratory of the Institute for Clinical Chemistry and Pathobiochemistry at the Klinikum rechts der Isar of the Technical University Munich, headed by Professor Peter B Luppa, organised the 4th of the internationally renowned Munich Point-of-Care Testing Symposiums. Dr Andreas Bietenbeck is senior physician at the Institute which for many years has been focusing on…
An up-and-coming gene therapy for blood disorders. A new class of medications for cystic fibrosis. Increased access to telemedicine. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of clinicians and researchers from Cleveland Clinic. In conjunction with the 2020 Medical Innovation Summit, Cleveland Clinic…
The vampire myth is likely related to a medical condition with symptoms that may explain many elements of centuries-old folklore. The concept of a vampire predates Bram Stoker’s tales of Count Dracula — probably by several centuries. But did vampires ever really exist? In 1819, 80 years before the publication of Dracula, John Polidori, an Anglo-Italian physician, published a novel called The…
Scientists at the University of Delaware and Princeton University have developed a method to monitor blood damage in real-time. “Our goal was to find a method that could detect red blood cell damage without the need for lab sample testing,” said Tyler Van Buren, an assistant professor of mechanical engineering with expertise in fluid dynamics. The researchers recently reported their technique…
A new, portable breast imaging system under development in Buffalo has the potential to better identify breast cancer in women with dense breast tissue. That is among the findings of a study published in the journal IEEE Transactions on Biomedical Engineering. The study was led by University at Buffalo researchers in collaboration with Roswell Park Comprehensive Cancer Center and Windsong…
Targeting medical treatment to an ailing body part is a practice as old as medicine itself. A Band-Aid is placed on a skinned knee. Drops go into itchy eyes. A broken arm goes into a cast. But often what ails us is inside the body and is not so easy to reach. In such cases, a treatment like surgery or chemotherapy might be called for. A pair of researchers in Caltech's Division of Engineering and…
Help for patients with sickle cell disease may soon come from gene editing to fix the mutation that causes the disease and boost the patient's own protective fetal hemoglobin.
A proof-of-principle study shows that gold nanoparticles loaded with CRISPR and other gene-editing tools safely and effectively edited blood stem cells.
Quo-Lab® HbA1c is a desktop point-of-care analyzer for measuring glycated hemoglobin (HbA1c). The semi-automated analyzer has been designed specifically to meet the needs of diabetes clinics and laboratories in settings that demand low cost of operation and ease of use. From a simple procedure, Quo-Lab provides lab-accurate test results within four minutes (CV < 3% at 7% A1c) from a venous or…
Inpeco FlexLab automation (Inpeco brand FlexLab) is now connected with Sebia Capillarys 3 TERA, Sebia’s latest generation capillary electrophoresis instrument.
Clinical laboratories need to meet greater testing demands, improve efficiency, and deliver reliable, high-quality results, while at the same time, facing an increasing shortage of skilled employees and growing budget constraints. Both patient and physician satisfaction are frequently tied to the time it takes to receive lab test results. In a recent survey commissioned by Siemens Healthineers,…
Donating blood is a tangible way to help people who are struggling with serious health conditions, yet many people may not think about it or make time for it. In January – which the American Red Cross has dubbed National Blood Donor Month – blood bank supplies are typically among the lowest of the year, as many people have been traveling or busy with the holidays. Inclement weather can also…
EKF Diagnostics, the global in vitro diagnostics company, introduces POC Connect - a data management smartphone application for its DiaSpect Tm hemoglobin analyzer. At Medica 2017 on Stand H3/C70, EKF will be highlighting how DiaSpect Tm is the only reagent-free hemoglobin analyzer with mobile connectivity. Lightweight and palm-sized, the DiaSpect Tm analyzer delivers laboratory quality…
Combining a new compound with old drugs could provide an effective remedy against malaria and drug-resistant parasites.
EKF Diagnostics announces that its newly introduced Glycated Serum Protein (GSP) LiquiColor® diabetic biomarker test has been verified for use on the Siemens Vista chemistry analyzer. In a scientific poster published by scientists at the Memorial Healthcare System, Hollywood, USA [1], it was demonstrated that EKF’s GSP assay enhances the versatility of the Vista system for the specialized…
EKF Diagnostics, the global in vitro diagnostics company, announces the publication of its new guide, "Anemia and hemoglobin testing". Available to download for free, the in-depth hematology guide provides a review of the symptoms and causes of anemia, through to methods for testing hemoglobin and hematocrit, as well as factors that may influence these measurements.
Findings demonstrate that testosterone is a metabolic hormone as well as a sex hormone, University at Buffalo researchers say.
At this year’s MEDICA, CNOGA Medical Ltd. will be introducing its new line of non-invasive, pain-free patient vital signs monitoring TensorTip™ devices, and presenting its new Singular™ platform, a secure cloud-based ecosystem infrastructure platform as well as its new mobile application for sending results to physicians, friends and caretakers. CNOGA’s easy-to-use, portable devices are…
Blood drawing for patients with hard-to-reach veins just became a lot easier and less painful at The Valley Hospital in Ridgewood, NJ, thanks to a small hand-held device that lights up veins like a roadmap. With the AccuVein illumination device, the need for multiple needle sticks to try to hit a good vein for a blood draw is a thing of the past.
The World Health Organization (WHO) estimated that in 2013, malaria infected 198 million people and killed 584,000, the majority of whom were African children. The compound that detectives spray at crime scenes to find trace amounts of blood may be used one day to kill the malaria parasite.
EKF Diagnostics, the global in vitro diagnostics company, announced the international launch of the Altair™ 240 clinical chemistry analyzer at the American Association for Clinical Chemistry’s (AACC) Annual Meeting and Clinical Lab Expo in Atlanta. This new bench-top platform represents EKF Diagnostics’ first fully integrated chemistry system designed for the global market. Also EKF…
Researchers have successfully tested two new potential methods for diagnosing and monitoring diabetes in its standard and gestational forms. These findings, presented at the 2015 AACC Annual Meeting & Clinical Lab Expo in Atlanta, may lead to easier, timelier, and more affordable ways of identifying and treating this chronic disease.
Inexpensive packing material pops up as an alternative to high-cost glass lab equipment for simple diagnostic tests, a potential boon in developing nations.
The new Hemo Control from EKF Diagnostics has the power to change the way you work. The next generation analyser provides accurate hemoglobin and hematocrit results in one simple test. Uniquely, the new hemoglobin POC analyser enables full upgrade with Data Management functionality as required, giving the user complete flexibility over their future connectivity options via its bi-directional…
Ahead of regulatory approval that is expected before the end of the year, Trinity Biotech chose Medica to present the novel point-of-care (POC) analyzer Meritas with the Troponin I (TnI) that are expected to disrupt a €700 million market.
Every year in Germany, four million wounds leave a legacy of 30 000 amputations and six billion Euros in treatment costs. These shocking figures drew wound experts to the Pflege Kongress 2012 (2012 Care Congress) held in Berlin.
A study published this week in Lancet suggests that low A1C levels may be just as dangerous as high A1C levels in diabetes patients with respect to mortality and cardiovascular outcomes. Upon review of the study, The Endocrine Society released a statement recommending against any wholesale change in glycemic goals and strongly encourages patients to discuss these issues with their diabetes-care…
What is good for the body may not be good for the mind. In an effort to repair heart damage with bypass surgery patients may experience unintended cerebral damage, including neuroligical impairment or even stroke.
Bayer HealthCare Diabetes Care unveiled the new CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.
Hutchinson's InSpectra StO2 Tissue Oxygenation Monitor - a portable device for treatment of trauma patients.